Following the recent pre-announcement of the NANOTECMEC call on research targeting Nano and advanced technologies for disease prevention, diagnostic and therapy, ERA4Health invites all potential project applicants to an information webinar and in collaboration with the European Technology platform on Nanomedcine (ETPN) to a matchmaking event:

Infoday – Tuesday 21st November 2023 from 10 to 12 am CET

In the webinar, the call documents and guidelines on how to apply for the call will be presented.

For participation, please register via the link below, until Monday 20 November at 13:00pm CET.

The registration link for the webinar is: 
http://enquetes.agencerecherche.fr/index.php/survey/index/sid/219556/lang/en

Matchmaking event – 7th December 2023 from 2 to 5 pm CET

In collaboration with ERA4Health, ETPN is hosting a matchmaking event to support the formation of new consortia. If you are interested in coordinating a consortium and are looking for partners with specific expertise, or if you would like to offer your expertise to a preformed consortium, this event is for you.

Registration: Participation is free. Secure your spot now BY CLICKING HERE.

Preparation: To make the most of the event, complete the Online Preparation Form by December 3rd, 6 PM (CET) BY CLICKING HERE

More information on the ETPN website: https://etp-nanomedicine.eu/nanotecmec-matchmaking/

For any inquiries or additional information on the matchmaking event, please do not hesitate to contact us at secretariat@etp-nanomedicine.fr.

The European Technology Platform on Nanomedicine (ETPN – www.etp-nanomedicine.eu) is an industry-led initiative established in 2005 in collaboration with the European Commission, to promote nanotechnology applications in healthcare. It became an independent association in 2015 and has over 130 members from 27 countries, representing various stakeholders in nanomedicine, from academia to SMEs, large industry and healthcare providers. The ETPN serves as a think tank for nanomedicine in Europe, supporting public funding for promising R&D topics and raising awareness. It also acts as a driving force for industrialization, detecting top innovations in nanomedicine and facilitating their access to clinical settings